awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38087999-4509D900-C5B4-4B95-BA9A-B50A4ABBD753
Q38087999-4509D900-C5B4-4B95-BA9A-B50A4ABBD753
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38087999-4509D900-C5B4-4B95-BA9A-B50A4ABBD753
The place of pemetrexed in the management of non-small-cell lung cancer patients.
P2860
Q38087999-4509D900-C5B4-4B95-BA9A-B50A4ABBD753
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38087999-4509D900-C5B4-4B95-BA9A-B50A4ABBD753
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
408a4e67c27a4e551d8f7e6d2c0b7b9a7fd8d8fa
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.